Robert Klupacs, Director at Bio-Gene Technology Ltd., holds 565.12K shares in Epiminder Ltd. (Ticker: AU:EPI), holds 3.96M shares in Bio-Gene Technology Ltd. (Ticker: AU:BGT), holds 475.45K shares in Opthea (Ticker: CKDXF). Most recently, Robert Klupacs Bought ― shares of Epiminder Ltd. on May 15, 2026 for an estimated value of AU$4.69K.
What is the percentage of profitable transactions made by Robert Klupacs?
The percentage of profitable transactions made by Robert Klupacs is 43%.
What is the average return per transaction made by Robert Klupacs?
The average return per transaction made by Robert Klupacs is 9.90%.
What stocks does Robert Klupacs hold?
Robert Klupacs holds: AU:BGT, CKDXF, AU:EPI stocks.
What was Robert Klupacs’s latest transaction?
Robert Klupacs latest transaction was an Informative Buy of AU$4.69K.
What was Robert Klupacs's most profitable transaction?
Robert Klupacs’s most profitable transaction was an Informative Buy of AU:BGT stock on March 1, 2021. The return on the trade was 134.40%.
What is Robert Klupacs's role in Bio-Gene Technology Ltd.?
Robert Klupacs's role in Bio-Gene Technology Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.